- Canada
- /
- Healthcare Services
- /
- TSX:AIDX
Healwell AI Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Healwell AI (TSE:AIDX) Third Quarter 2024 Results
Key Financial Results
- Revenue: CA$13.7m (up 399% from 3Q 2023).
- Net loss: CA$10.6m (loss widened by 39% from 3Q 2023).
- CA$0.06 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Healwell AI Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 6.2%. Earnings per share (EPS) missed analyst estimates by 30%.
Looking ahead, revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Healthcare industry in Canada.
Performance of the Canadian Healthcare industry.
The company's shares are up 11% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with Healwell AI (including 1 which is potentially serious).
Valuation is complex, but we're here to simplify it.
Discover if Healwell AI might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSX:AIDX
Healwell AI
A healthcare technology company, focuses on AI and data science for preventative care.
Excellent balance sheet with limited growth.